oral
andor
intranas
inocul
suscept
mous
genotyp
jhm
strain
mous
hepat
viru
mhvjhm
consist
result
cell
dysfunct
reflect
vitro
prolif
respons
mitogen
allogen
cell
one
approach
examin
mechan
respons
observ
function
cell
suppress
determin
whether
viru
replic
requir
induct
end
mice
inocul
oronas
mhvjhm
inactiv
shortwav
ultraviolet
light
betapropiolacton
psoralen
mice
also
inocul
live
mhvjhm
recoveri
homotyp
heterotyp
mhv
infect
spleen
cell
balb
mice
inocul
oronas
inactiv
mhvjhm
yield
extrem
variabl
vitro
prolif
respons
concanavalin
stimul
mhvsuscept
mice
expos
oronasauy
intraperiton
viru
inactiv
minimum
effect
treatment
fail
seroconvert
immun
psoralentr
viru
intraperiton
freund
complet
adjuv
oronas
fail
protect
live
viru
challeng
survivor
elev
virusspecif
serum
igg
antibodi
titer
compar
mockimmun
control
two
week
postchalleng
spleen
cell
mice
challeng
recoveri
homotyp
live
viru
infect
exhibit
profound
vitro
cell
suppress
normal
observ
acut
stage
primari
infect
contrast
mhvjhm
challeng
mice
vaccin
heterotyp
live
mhv
result
significantli
depress
vitro
celt
function
combin
data
suggest
either
viru
replic
exposur
concentr
antigen
may
requir
induct
dramat
cell
dysfunct
occur
consequ
mhvjhm
infect
well
detect
mhvspecif
humor
respons
mous
hepat
viru
mhv
highli
contagi
coronaviru
infect
laboratori
mice
worldwid
high
preval
usual
without
clinic
sign
impact
infect
research
involv
mice
enorm
sever
advers
effect
biolog
respons
mice
demonstr
infect
potenti
render
experiment
result
number
disciplin
invalid
major
advers
effect
mhv
infect
immunomodut
prior
studi
shown
suscept
strain
mice
balb
c
sustain
transient
suppress
cell
function
consequ
infect
natur
rout
jhm
strain
mhv
import
issu
pertain
mechan
respons
immunosuppress
whether
viru
replic
requir
induct
studi
virus
yield
vari
result
measl
virusassoci
inhibit
mitogendriven
prolifer
immunoglobulin
product
elimin
uvor
heatinactiv
viru
use
immunosuppress
variant
parvoviru
minut
viru
mice
inhibit
appear
cytotox
cell
mix
lymphocyt
cultur
use
form
uvinactiv
viru
purifi
viral
capsid
live
newcastl
diseas
viru
achiev
full
replic
cycl
murin
cell
induc
suppress
concanavalin
con
driven
allogen
respons
mice
wherea
uvinactiv
viru
contrast
inhibit
poxviru
dna
polymeras
phosphonoacet
acid
affect
abil
malign
rabbit
fibroma
viru
suppress
lymphocyt
prolifer
initi
antibodi
product
prolifer
bovin
peripher
blood
mononuclear
cell
stimul
either
con
interleukin
il
inhibit
bovin
herpesviru
although
less
cell
product
infect
model
system
use
human
peripher
blood
lymphocyt
vesicular
stomat
viru
sendal
viru
friend
leukemia
viru
herp
viru
type
batteri
avian
retrovirus
known
incap
enter
infect
human
lymphocyt
live
uvinactiv
virus
abrog
prolif
respons
mitogen
con
phytohemagglutinin
allogen
cell
thu
abil
replicationdefect
viru
alter
immun
function
unpredict
major
goal
studi
determin
whether
cell
dysfunct
observ
mhv
inocul
suscept
genotyp
natur
rout
due
directli
activ
viru
infect
indirectli
interact
mhv
antigen
goal
address
character
respons
mice
expos
viru
inactiv
sever
physic
chemic
method
mice
challeng
recoveri
live
viru
immun
mhvjhm
mhv
american
type
cultur
collect
rockvil
md
use
fonxl
infect
infant
mous
brain
homogen
viru
stock
titer
intracerebr
infant
mous
per
ml
mice
inocul
oronas
receiv
mice
inocul
intraperiton
receiv
viru
femal
balbcbyj
balb
mice
jackson
laboratori
bar
harbor
four
week
old
time
initi
viru
exposur
cr
orl
sencar
hereaft
refer
sencar
dam
litter
weanl
femal
sencar
nih
swiss
mice
obtain
anim
genet
product
branch
nci
frederick
md
randomli
select
mice
free
antibodi
common
murin
virus
arriv
mice
hous
microisol
cage
lab
product
maywood
nj
given
food
water
ad
libitum
manipul
husbandri
perform
class
ii
biolog
safeti
cabinet
opencag
sentinel
mous
seromonitor
program
place
cours
report
studi
seroconvers
none
common
murin
virus
mycoplasma
pulmoni
detect
except
among
select
mhvinocul
mice
detail
result
betapropiolacton
acid
lacton
sigma
chemic
co
st
loui
mo
use
stock
solut
psoralen
hydrochlorid
hri
associ
inc
emeryvil
ca
prepar
mgml
stock
solut
ethyl
alcohol
store
room
temperatur
lighttight
contain
use
final
concentr
ggml
concanavalin
con
sigma
chemic
co
use
final
concentr
ggml
rat
monoclon
antibodi
mous
design
design
l
lbll
origin
obtain
mosmann
j
ohara
w
e
paul
b
kindli
provid
dr
kim
bottomli
section
immunobiolog
howard
hugh
medic
institut
yale
univers
shortwav
ultraviolet
uv
irradi
result
format
pyrimidin
dimer
accomplish
expos
thin
layer
stock
viru
glass
petri
dish
within
ice
bath
gte
germicid
lamp
distanc
six
inch
betapropiolacton
bpl
alkyl
agent
react
guanidin
residu
rna
dna
consid
moder
effect
maintain
antigen
structur
bpl
inactiv
accomplish
ad
one
volum
stock
solut
nine
volum
stock
viru
mixtur
incub
h
water
bath
aliquot
store
psoralen
natur
occur
aromat
compound
found
mani
fruit
veget
chemic
inert
expos
longwav
uv
light
result
direct
photoreact
nucleic
acid
linear
psoralen
molecul
intercal
doubl
helic
region
form
coval
adduct
pyrimidin
base
usual
thymidin
dna
uridin
rna
bond
form
firmli
link
togeth
prevent
separ
doubl
helic
nucleic
acid
strand
without
disrupt
protein
structur
psoralen
inactiv
hydrochlorid
ad
final
concentr
ixgml
shallow
layer
stock
viru
petri
dish
manual
swirl
irradi
period
transfer
ice
bath
sampl
period
ultraviolet
irradi
accomplish
longwav
uv
transillumin
model
uvp
inc
san
gabriel
ca
emit
wavelength
nm
averag
intens
twcm
aliquot
remov
prior
uv
light
exposur
min
store
viru
prepar
treat
describ
assay
intracerebr
inocul
twodayold
sencar
mice
observ
daili
mortal
infant
mous
bioassay
current
serv
sensit
test
mhv
infect
addit
liver
balb
mice
inocul
oronas
either
uvinactiv
bpltreat
mhv
use
function
cell
assay
process
histolog
fix
neutral
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
concentr
infecti
viru
liver
high
acut
phase
activ
infect
correl
liver
histopatholog
viru
recoveri
major
target
organ
smith
barthold
unpubl
ob
inactiv
psoralentr
mhvjhm
confirm
inabl
primer
specif
segment
gene
amplifi
polymeras
chain
reaction
antigen
viru
confirm
inactiv
test
intraperiton
andor
oronas
inocul
weanl
sencar
balb
mice
exsanguin
day
later
sera
screen
mhv
antibodi
indirect
immunofluoresc
ifa
use
sera
dilut
bival
mhvjhmmhv
antigen
igg
enzym
immunoassay
eia
use
sera
dilut
mhvjhm
antigen
previous
describ
antibodi
titer
determin
eia
con
astimul
prolifer
measur
previous
describ
briefli
spleen
cell
individu
balb
mice
expos
oronas
inactiv
live
viru
four
five
seven
day
earlier
suspend
ml
rpmi
medium
gibco
brl
gaithersburg
md
contain
fetal
bovin
serum
gibco
brl
mm
sigma
chemic
co
mm
lglutamin
gibco
brl
rpmi
cell
suspens
dilut
need
filter
normal
salin
contain
trypan
blue
ammonium
chlorid
determin
viabl
nucleat
cell
count
cell
wash
adjust
x
l
viabl
cell
per
ml
rpmi
cell
suspens
ad
well
cluster
dish
set
four
six
replic
well
receiv
tl
rpmi
tl
con
cell
incub
humidifi
atmospher
label
tci
per
well
methyl
thymidin
dupont
nen
boston
ci
per
retool
h
prior
collect
glass
fiber
filter
scintil
count
cultur
harvest
either
h
h
interv
day
result
express
mean
cpm
con
atreat
cellsmean
cpm
rpmi
cell
supern
collect
spleen
cell
cultur
con
rpmi
assi
cell
describ
earlier
supern
con
astimul
cultur
induc
prolifer
cell
serial
dilut
retest
monoclon
antibodi
viru
expos
psoralen
longwav
uv
light
rain
use
vaccin
weanl
mice
balb
mice
twice
vaccin
oronas
two
week
interv
nih
swiss
mice
inocul
intraperiton
kill
viru
emulsifi
freund
complet
adjuv
boost
oronas
two
week
later
control
mice
similarli
inocul
steril
cultur
medium
uninfect
infant
mous
brain
homogen
emulsift
freund
complet
adjuv
two
week
booster
dose
drop
blood
collect
tip
tail
serolog
mice
challeng
intranas
live
mhvjhm
mice
observ
mortal
exsanguin
day
postchalleng
determin
effect
prior
vaccin
live
viru
vitro
cell
function
subsequ
challeng
balb
mice
inocul
oronas
steril
cultur
medium
mhvjhm
mhv
four
week
interv
mice
fulli
recov
oronasat
mhv
infect
small
blood
sampl
collect
verifi
seroconvers
mice
challeng
oronas
mhvjhm
con
ainduc
prolifer
product
spleen
cell
collect
four
day
challeng
measur
describ
base
infant
mous
bioassay
mhvjhm
complet
inactiv
exposur
germicid
uv
lamp
ten
minut
weanl
balb
mice
expos
oronas
materi
use
function
cell
assay
histolog
normal
liver
four
seven
day
postinocul
confirm
inactiv
inoculum
mice
alsofail
seroconvert
mice
similarli
expos
live
viru
seroconvert
seven
day
postinocul
moder
hepat
day
increas
sever
day
con
astimul
prolif
respons
spleen
cell
five
six
mice
assay
four
day
exposur
uvinactiv
mhv
significantli
reduc
compar
control
respons
tabl
spleen
cell
one
mous
hyperrespons
day
cell
four
six
mice
receiv
uvinactiv
h
v
prolifer
poorli
compar
control
cell
two
mice
hyperrespons
cell
activ
infect
mice
still
function
suppress
interv
prolif
valu
control
tabl
product
cultur
spleen
cell
gener
correl
prolif
capac
tabl
data
shown
uvinactiv
viru
repres
one
three
replic
experi
yield
similarli
highli
variabl
respons
cell
mice
given
kill
mhvjhm
balb
mice
given
bplinactiv
mhvjhm
oronas
day
prior
necropsi
histolog
normal
liver
confirm
viru
inactiv
mice
fail
seroconvert
day
mice
similarli
expos
live
viru
sever
hepat
day
seven
seroposit
day
con
astimul
prolif
respons
spleen
cell
mice
given
bplinactiv
h
v
seven
day
earlier
consist
elev
compar
control
respons
wherea
respons
cell
activ
infect
mice
rang
control
prolifer
tabl
mousetomous
variabl
sencar
pup
per
group
expos
intracerebr
viru
treat
psoralen
two
minut
longer
surviv
fig
viru
collect
interv
exceed
two
minut
inocul
intraperiton
group
four
weanl
sencar
mice
surviv
three
week
none
develop
h
v
antibodi
five
b
l
b
mice
expos
oronas
viru
treat
three
minut
psoralen
longwav
uv
light
spleen
cell
prolif
respons
measur
five
day
later
fig
prolifer
ceil
cultur
two
six
day
essenti
ident
cell
three
naiv
control
mice
contrast
prolifer
spleen
cell
deriv
four
activ
infect
mice
significantli
reduc
peak
prolifer
oc
cur
later
control
cell
report
earlier
immunogen
psoraleninactiv
mhvjhm
test
three
vaccinationchalleng
experi
tabl
data
pool
two
experi
balb
mice
twice
expos
oronas
psoralentr
viru
yield
ident
mortal
rate
averag
surviv
time
day
vaccin
control
mice
experi
yield
modestli
elev
post
tabl
nih
swiss
mice
expos
intraperiton
psoralentr
viru
emulsifi
freund
complet
adjuv
boost
oronas
also
protect
challeng
significantli
elev
postchalleng
virusspecif
igg
antibodi
titer
tabl
none
mice
test
day
live
viru
challeng
mhv
seroposit
spleen
cell
four
mockvaccin
balb
mice
challeng
mhvjhm
prolifer
level
control
spleen
cell
prolifer
tabl
cell
also
produc
neglig
concentr
contrast
cell
four
mice
immun
homolog
mhvjhm
viru
yield
prolif
respons
control
respons
tabl
spleen
cell
six
mice
vaccin
heterolog
mhv
viru
prolifer
level
less
control
prolifer
tabl
prolifer
cell
remain
six
mice
rang
control
prolifer
product
gener
correl
magnitud
prolif
respons
tabl
serial
dilut
yield
expect
doserespons
curv
data
shown
ifa
test
sera
mhvjhmand
mhvsimmun
mice
reveal
mice
mhv
antibodyposit
time
mhvjhm
challeng
wherea
sera
control
mice
mockvaccin
contain
detect
antibodi
four
day
mhvjhm
challeng
sera
control
mice
mockvaccin
mice
contain
mhvjhmreactiv
eia
antibodi
tabl
mice
vaccin
mhvjhm
high
titer
serum
igg
antibodi
geometr
mean
eia
titer
sera
seen
seven
day
inocul
cell
two
six
mice
hyperrespons
interv
cell
four
four
mice
given
bplinactiv
viru
test
seven
day
later
hyperrespons
respons
cell
mice
given
uvtreat
mhvjhm
quit
variabl
three
separ
experi
despit
fact
confirm
viru
inactiv
obtain
inocul
mous
spleen
cell
mice
given
psoralentr
viru
yield
con
ainduc
prolif
respons
essenti
ident
cell
naiv
control
mice
mousetomous
variat
minim
among
anim
receiv
psoralentr
mhvjhm
inactiv
method
use
psoralen
treatment
least
harsh
therefor
least
like
caus
conform
chang
structur
protein
lack
detect
virusspecif
humor
respons
even
two
exposur
psoralentr
viru
includ
one
parenter
inject
freund
complet
adjuv
render
interpret
conclus
difficult
could
argu
howev
immun
system
mice
twice
immun
psoraleninactiv
viru
stimul
sinc
mice
consist
albeit
margin
case
oronas
inocul
elev
antibodi
titer
compar
mockvaccin
mice
live
viru
challeng
mice
given
mhvjhm
inactiv
method
describ
clearli
receiv
enough
antigen
induc
seroconvers
may
also
argu
oronas
exposur
kill
viru
may
less
like
stimul
immun
respons
parenter
inocul
without
adjuv
howev
research
program
histor
devot
studi
mhv
natur
pathogen
laboratori
mice
therefor
alway
use
natur
rout
exposur
studi
immunosuppress
live
mhvjhm
document
perform
mice
infect
oral
intranas
combin
rout
therefor
seem
reason
essenti
expos
mice
kill
viru
natur
rout
attempt
determin
whether
viru
could
induc
immun
dysfunct
accumul
data
studi
use
three
inactiv
method
also
provid
support
notion
viru
replic
exposur
antigen
requir
induct
detect
antibodi
respons
protect
challeng
mhvjhm
contrast
report
virus
instanc
arthropodborn
virus
ecolog
relat
virus
caus
high
mortal
among
peripher
inocul
mice
frequent
bplinactiv
order
prepar
immun
sera
report
immunogen
psoralentr
viru
rare
howev
psoraleninactiv
crude
pichind
viru
without
adjuv
induc
seroconvers
among
intramuscularli
inject
guinea
pig
within
two
week
guinea
pig
given
two
dose
viru
dilut
without
adjuv
also
seroconvert
addit
method
report
also
evalu
abil
formalininactiv
mhvjhm
induc
antibodi
respons
use
modif
recent
publish
techniqu
studi
inocul
mice
respons
mous
hepat
viru
immun
lactic
dehydrogenas
elev
viru
treat
formalin
long
h
yield
hybridoma
produc
viru
neutral
antibodi
treatment
mhvjhm
formalin
rain
minimum
effect
treatment
time
result
complet
loss
infect
howev
sencar
mice
inocul
oronas
intraperiton
materi
seroconvert
test
day
later
formalin
seem
reason
treatment
choic
sinc
higher
concentr
destroy
mhv
antigen
possibl
antibodi
respons
could
stimul
parenter
inocul
mice
inactiv
mhvjhm
potent
adjuv
perhap
sever
booster
exclud
howev
state
major
goal
report
studi
character
cell
function
mice
given
kill
viru
natur
rout
view
high
preval
mhv
infect
rapid
viru
transmit
throughout
coloni
control
mean
elimin
agent
case
ectromelia
mousepox
viru
seem
unlik
possibl
one
strategi
develop
vaccin
might
provid
protect
without
function
immun
deficit
document
live
viru
administr
sinc
protect
challeng
afford
psoraleninactiv
viru
immun
function
mice
challeng
live
viru
vaccin
evalu
design
live
viru
vaccinationchalleng
experi
report
ident
describ
earlier
report
complet
resist
homotyp
challeng
demonstr
earlier
studi
balb
mice
challeng
day
immun
infect
mhvjhm
histolog
normal
liver
nose
four
day
challeng
viru
detect
liver
interv
strong
evid
homotyp
live
viru
vaccin
protect
infect
upon
challeng
contrast
mice
immun
biolog
similar
antigen
distinct
mhv
fulli
suscept
mhvjhm
challeng
base
criteria
present
studi
spleen
cell
mice
challeng
mhvjhm
recoveri
homotyp
infect
yield
con
ainduc
prolif
respons
suppress
extent
observ
cell
mice
undergo
primari
infect
mock
jhm
tabl
function
cell
mice
immun
live
mhv
challeng
mhvjhm
suppress
manner
similar
cell
mice
sustain
primari
infect
data
affirm
differ
methodolog
earlier
report
highli
strainspecif
challeng
immun
murin
coronavirus
studi
strongli
suggest
polyval
vaccin
would
requir
protect
mice
infect
mani
mhv
strain
circul
anim
coloni
current
experi
suggest
caveat
howev
even
polyval
vaccin
might
elimin
deleteri
effect
mhv
vitro
assay
immun
function
sinc
function
cell
mice
challeng
homotyp
viru
depress
albeit
extent
seen
mock
vaccin
challeng
therefor
efficaci
test
candid
vaccin
includ
studi
determin
whether
vaccin
tabl
unexpect
sinc
h
v
j
h
eia
use
detect
mhv
antibodi
sera
mice
inject
intraperiton
infect
mous
brain
homogen
sera
mhvsimmun
mice
contain
h
v
antibodi
base
ifa
test
bival
antigen
eia
use
antigen
infect
cell
monolay
cell
fuse
syncytium
format
h
v
reli
presenc
surfac
glycoprotein
also
protein
neutral
protect
antibodi
direct
matur
viru
particl
releas
cultur
medium
may
also
precipit
formalin
ad
inactiv
viru
prior
assay
thu
modifi
enzym
immunoassay
may
certain
condit
like
detect
strainspecif
antibodi
assay
use
immobil
solubl
antigen
whether
rout
inocul
play
role
current
unknown
howev
high
mhvjhmspecif
antibodi
titer
posit
correl
studi
rel
complet
protect
mhvjhminduc
immun
dysfunct
